- Home
- JYNT vs EPIX Comparison
JYNT vs EPIX Comparison
Compare JYNT & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- EPIX
- Stock Information
- Founded
- JYNT 2010
- EPIX 2009
- Country
- JYNT United States
- EPIX Canada
- Employees
- JYNT N/A
- EPIX N/A
- Industry
- JYNT Multi-Sector Companies
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- JYNT Miscellaneous
- EPIX Health Care
- Exchange
- JYNT Nasdaq
- EPIX Nasdaq
- Market Cap
- JYNT 179.2M
- EPIX 209.4M
- IPO Year
- JYNT 2014
- EPIX N/A
- Fundamental
- Price
- JYNT $11.57
- EPIX $1.76
- Analyst Decision
- JYNT Strong Buy
- EPIX Hold
- Analyst Count
- JYNT 2
- EPIX 4
- Target Price
- JYNT $17.50
- EPIX $9.50
- AVG Volume (30 Days)
- JYNT 53.8K
- EPIX 2.4M
- Earning Date
- JYNT 11-07-2024
- EPIX 12-10-2024
- Dividend Yield
- JYNT N/A
- EPIX N/A
- EPS Growth
- JYNT N/A
- EPIX N/A
- EPS
- JYNT N/A
- EPIX N/A
- Revenue
- JYNT $120,795,620.00
- EPIX N/A
- Revenue This Year
- JYNT $0.70
- EPIX N/A
- Revenue Next Year
- JYNT N/A
- EPIX N/A
- P/E Ratio
- JYNT N/A
- EPIX N/A
- Revenue Growth
- JYNT 5.26
- EPIX N/A
- 52 Week Low
- JYNT $8.60
- EPIX $1.40
- 52 Week High
- JYNT $17.82
- EPIX $11.67
- Technical
- Relative Strength Index (RSI)
- JYNT 53.06
- EPIX 24.56
- Support Level
- JYNT $10.65
- EPIX $1.66
- Resistance Level
- JYNT $12.70
- EPIX $1.89
- Average True Range (ATR)
- JYNT 0.49
- EPIX 0.12
- MACD
- JYNT -0.03
- EPIX 0.05
- Stochastic Oscillator
- JYNT 44.88
- EPIX 62.86
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.